Skip to main content

Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.